Foke van Delft

763 total citations
10 papers, 373 citations indexed

About

Foke van Delft is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Foke van Delft has authored 10 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Foke van Delft's work include Gallbladder and Bile Duct Disorders (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Microbial Inactivation Methods (2 papers). Foke van Delft is often cited by papers focused on Gallbladder and Bile Duct Disorders (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Microbial Inactivation Methods (2 papers). Foke van Delft collaborates with scholars based in Netherlands, United States and United Kingdom. Foke van Delft's co-authors include Andra Neefjes‐Borst, Adriaan A. van Bodegraven, Nanne K.H. de Boer, Jelle Haringsma, Evelien Dekker, Arjun D. Koch, Lucio Petruzziello, Pietro Familiari, Adam Haycock and Siwan Thomas‐Gibson and has published in prestigious journals such as Radiology, World Journal of Gastroenterology and Gastrointestinal Endoscopy.

In The Last Decade

Foke van Delft

7 papers receiving 363 citations

Peers

Foke van Delft
Stojan Potrč Slovenia
Ami M. Karkar United States
Robin A. Raymer United States
Arpad Ivanecz Slovenia
Charles R. St. Hill United States
K.J. Barbery United States
R Keller Germany
Hao Cui China
Stojan Potrč Slovenia
Foke van Delft
Citations per year, relative to Foke van Delft Foke van Delft (= 1×) peers Stojan Potrč

Countries citing papers authored by Foke van Delft

Since Specialization
Citations

This map shows the geographic impact of Foke van Delft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Foke van Delft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Foke van Delft more than expected).

Fields of papers citing papers by Foke van Delft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Foke van Delft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Foke van Delft. The network helps show where Foke van Delft may publish in the future.

Co-authorship network of co-authors of Foke van Delft

This figure shows the co-authorship network connecting the top 25 collaborators of Foke van Delft. A scholar is included among the top collaborators of Foke van Delft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Foke van Delft. Foke van Delft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Delft, Foke van, Erwin-Jan M. van Geenen, Auke Bogte, et al.. (2025). Endoscopic ultrasound-guided choledochoduodenostomy results in fewer complications than percutaneous drainage following failed ERCP in malignant distal biliary obstruction. Endoscopy. 57(9). 1004–1015. 1 indexed citations
3.
Delft, Foke van, Peter D. Siersema, Christina J. Sperna Weiland, et al.. (2024). Heterozygous Variant of CYP2C8∗3 is a Protective Factor for Developing Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Clinical Gastroenterology and Hepatology. 23(6). 1068–1070.e2.
4.
Scheffer, Hester J., Laurien G. P. H. Vroomen, Marcus C. de Jong, et al.. (2016). Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study. Radiology. 282(2). 585–597. 103 indexed citations
5.
Gils, Tom van, Tine van de Donk, Gerd Bouma, et al.. (2016). The first cases of collagenous sprue successfully treated with thioguanine. BMJ Open Gastroenterology. 3(1). e000099–e000099. 5 indexed citations
6.
Vroomen, Laurien G. P. H., Hester J. Scheffer, Marleen C. A. M. Melenhorst, et al.. (2016). MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation. European Radiology. 27(6). 2521–2531. 35 indexed citations
7.
Delft, Foke van, et al.. (2015). Clinical, Endoscopic, and Histologic Characteristics of Ipilimumab-Associated Colitis. Clinical Gastroenterology and Hepatology. 14(6). 836–842. 112 indexed citations
8.
Haycock, Adam, Arjun D. Koch, Pietro Familiari, et al.. (2009). Training and transfer of colonoscopy skills: a multinational, randomized, blinded, controlled trial of simulator versus bedside training. Gastrointestinal Endoscopy. 71(2). 298–307. 93 indexed citations
9.
Haycock, Adam, Arjun D. Koch, Pietro Familiari, et al.. (2009). Colonoscopy Skills Transfer from a Second-Generation Virtual Reality Simulator to Patients: A Multinational Randomized Blinded Controlled Trial. Gastrointestinal Endoscopy. 69(5). AB220–AB220. 1 indexed citations
10.
Waardenburg, Robert C.A.M. van, Foke van Delft, Maria A.J. van Eijndhoven, et al.. (2004). Homologous recombination is a highly conserved determinant of the synergistic cytotoxicity between cisplatin and DNA topoisomerase I poisons. Molecular Cancer Therapeutics. 3(4). 393–402. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026